Weekly alendronate versus risedronate for postmenopausal osteoporosis--is there a difference?

Affiliations

Comment

Carolyn B Becker. Nat Clin Pract Endocrinol Metab. 2007 Feb.

. 2007 Feb;3(2):90-1.

doi: 10.1038/ncpendmet0389.

¹ College of Physicians and Surgeons, Columbia University Medical Center, New York, NY, USA. cb2006@columbia.edu

No abstract available

Comment on

Comparison of weekly treatment of postmenopausal osteoporosis with alendronate versus risedronate over two years.
Bonnick S, Saag KG, Kiel DP, McClung M, Hochberg M, Burnett SM, Sebba A, Kagan R, Chen E, Thompson DE, de Papp AE. Bonnick S, et al. J Clin Endocrinol Metab. 2006 Jul;91(7):2631-7. doi: 10.1210/jc.2005-2602. Epub 2006 Apr 24. J Clin Endocrinol Metab. 2006. PMID: 16636120 Clinical Trial.